Talphera, Inc.

Industry

  • Medical Devices
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Drug Delivery

Other Names/Subsidiaries

  • AcelRx Pharmaceuticals
  • Lowell Therapeutics
  • SuRx Pharmaceuticals
See more in Biomedtracker

Latest on Talphera, Inc.

Scrip

Deal Watch: Vertex Calls On CRISPR Yet Again, Now To Collaborate On Type 1 Diabetes

 
• By Joseph Haas and Mandy Jackson

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. New Vertex/CRISPR Pact Centers On Gene-

Pink Sheet

Despite Few Actions On Rx Drug Promos, US FDA Increased Engagement With Stakeholders Last Year

 
• By Brenda Sandburg

On the surface, the US Food and Drug Administration’s Office of Prescription Drug Promotion seems to have had a quiet year in 2021 issuing just six enforcement letters and initiating only three resear

HBW Insight

Califf Likely To Find Many Familiar Problems Upon Return To US FDA Helm

 
• By Derrick Gingery

Should Robert Califf gain a second term as FDA commissioner, he likely will find that many of the issues demanding attention remain the same as when he left the agency five years ago, even though the

Pink Sheet

Robert Califf Likely To Find Many Familiar Problems Upon His Return To US FDA

 
• By Derrick Gingery

Should Robert Califf gain a second term as FDA commissioner, he likely will find that many of the issues demanding attention remain the same as when he left the agency five years ago, even though the